The global Bone Regeneration Market is expected to be worth US$ 5.1 billion in 2022 and to grow at a CAGR of 3.8% to reach US$ 7.4 billion by 2032. In terms of product type, bone graft substitutes dominated the market in 2021, accounting for 81.4% of the market.
A well-organized and complex physiological process of bone growth is referred to as bone regeneration. Bone insufficiency is the cause of certain bone issues. The intricate process of bone regeneration necessitates bone remodelling. Musculoskeletal disorders are becoming more common across the globe. Prevalence of common musculoskeletal disorders like osteoarthritis, osteoporosis, and joint inflammation are increasing, which is resulting growth in the market.
Additionally, as the per-care cost is continuing to rise each year, increasing global health spending, the treatment for these conditions contributes to the overall cost of pharmaceutical charges. The improved reimbursement scenario covers orthopaedic sector treatment. Medicare, for instance, spent US$ 799.4 billion in 2019 on benefit payments for roughly 61 million people who were 65, older, or disabled.
Get a Full PDF Sample Copy of the Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-15486
Medicaid, on the other hand, spent US$138.7 billion on acute care services like hospitalization, visits to the doctor, and prescribed medications in the same year. More patients can choose the treatment when there is a better reimbursement scenario. Future growth in the market for bone regeneration is projected because this factor, is positive. The demand for bone regeneration is expected to rise during the forecast period due to the development of novel, advanced technologies.
Key Takeaways from Bone Regeneration Study
- Bone grafts substitute as products are expected to hold around 83.4% market value share by the end of 2032, and are expected to display a CAGR growth of 4.1% over the forecast period.
- By application, trauma cases hold a dominant market share value of 22.6% in 2021 in the global market. As trauma is the most common cause of death it leads to a positive growth during the forecast period.
- By age group, the adult segment holds a dominant market share value of 56.8% in 2021 in the global market.
- Hospitals hold a higher end-user segment share in terms of the market share value of 49.1% in 2021. Most surgeries need a proper operating environment because it is critical and time-consuming. To ensure patient safety, most surgeries take place in hospitals.
- North America is slated to be the largest leading region with an estimated market value of 39.0% at the end of the forecast period. Owing to the high prevalence of joint diseases in the region.
“Increasing prevalence of orthopedic diseases, rising incidence of bone fractures is expected to drive demand for bone regeneration market during the next decade,” says the FMI Analyst
Inquire Before Buying Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-15486
Market Competition
The market for bone regeneration is moderately fragmented, and there exist, several local, emerging, as well as established players within the market sphere. Key players have initiated promotional activities to introduce new products with continued collaboration and expansion activities
- Johnson & Johnson gained 510(k) FDA clearance in November 2021 for the VELYSTM Robotic-Assisted Solution for use with the ATTUNE® Total Knee System, giving surgeons the chance to streamline their current workflows on a typical orthopedic procedure.
- Altapore Shape bioactive bone graft, the newest addition to Baxter’s line of next-generation bone graft substitutes, was approved by the U.S. Food and Drug Administration (FDA) in September 2020.
Key Players:
- Medtronic plc.
- Stryker Corporation
- DePuy Synthes, Inc.
- Integra Lifesciences Holdings Corporation
- Zimmer Biomet Holdings, Inc.
- Xtant Medical Holdings, Inc.
- Arthrex, Inc.
- Baxter International Inc.
- Musculoskeletal Transplant Foundation
- Smith & Nephew, Inc.
- Orthofix Holdings, Inc.
- Others
Get Your Report Customize, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-15486
Key Market Segments Covered in Bone Regeneration Industry Research
By Product:
- Bone Grafts Substitutes
- Allografts
- Demineralized Bone Matrix(DBM)
- Others
- Xenograft
- Autografts
- Synthetic Bone Graft
- Bone Morphogenetic Protein(BMP)
- Allografts
- Bone Growth Stimulators
- Non-Invasive Electrical Bone Growth Stimulators
- Invasive Electrical Bone Growth Stimulators
By Application:
- Osteoarthritis (OA)
- Osteoporosis
- Rheumatoid Arthritis (RA)
- Spinal Disorders
- Dentistry
- Craniomaxillofacial (CMF)
- Trauma Cases
By Age Group:
- Pediatric
- Adults
- Geriatric
By End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
